Overview Long-term Study of DSP-5423P in Patients With Schizophrenia Status: Completed Trial end date: 2017-05-01 Target enrollment: Participant gender: Summary The study evaluates the long term safety of DSP-5423P in patients with schizophrenia. Phase: Phase 3 Details Lead Sponsor: Sumitomo Dainippon Pharma Co., Ltd.